HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Andrew Carlson Selected Research

Pigmented Nevus (Melanocytic Nevus)

2/2011Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" a case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi.
4/2010The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
3/2003Biomarkers in melanoma: predisposition, screening and diagnosis.
8/2002Actin-binding protein fascin expression in skin neoplasia.
1/2002Melanocytic proliferations associated with lichen sclerosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J Andrew Carlson Research Topics

Disease

19Neoplasms (Cancer)
10/2013 - 05/2002
13Melanoma (Melanoma, Malignant)
10/2013 - 01/2002
11Vasculitis (Vasculitides)
11/2015 - 10/2005
9Infection
10/2012 - 06/2002
7Wounds and Injuries (Trauma)
11/2011 - 05/2002
5Neoplasm Metastasis (Metastasis)
10/2013 - 08/2002
5Pigmented Nevus (Melanocytic Nevus)
02/2011 - 01/2002
4Cicatrix (Scar)
04/2013 - 04/2002
4Endarteritis
04/2013 - 02/2007
4Dermatitis
10/2012 - 02/2007
4Lymphedema (Milroy Disease)
10/2012 - 03/2007
4Hyperplasia
10/2012 - 10/2005
4Necrosis
08/2010 - 08/2004
4Purpura
04/2008 - 09/2006
3Carcinoma (Carcinomatosis)
10/2012 - 08/2002
3Granuloma
07/2012 - 12/2006
3Warts (Wart)
04/2011 - 08/2008
3Inflammation
01/2010 - 12/2005
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009 - 02/2004
3Epidermodysplasia Verruciformis
08/2008 - 02/2007
3Ulcer
01/2008 - 09/2006
3Gangrene
01/2008 - 09/2006
2Rosacea (Acne Rosacea)
07/2013 - 02/2008
2Nevus (Nevi)
10/2012 - 08/2008
2Whipple Disease (Whipple's Disease)
04/2012 - 02/2009
2Cysts
08/2011 - 08/2010
2Epidermal Cyst (Sebaceous Cyst)
08/2011 - 05/2002
2Eosinophilia
01/2010 - 12/2006
2Erythema
12/2008 - 01/2008
2Hyperpigmentation
04/2008 - 04/2002
2Arteritis
04/2008 - 02/2007
2Vulvitis
03/2008 - 10/2003
2Rheumatoid Vasculitis
01/2008 - 09/2006
2Wegener Granulomatosis (Wegener's Granulomatosis)
01/2008 - 09/2006
2Churg-Strauss Syndrome (Allergic Angiitis)
01/2008 - 09/2006
2Connective Tissue Diseases (Connective Tissue Disease)
02/2007 - 12/2006
2Hemorrhage
02/2007 - 12/2005
2Adenocarcinoma
02/2004 - 08/2002
1Lyme Disease (Disease, Lyme)
06/2015
1Adenoid Cystic Carcinoma (Cylindroma)
02/2013
1Wilms Tumor (Wilm's Tumor)
02/2013
1Nasal Obstruction
07/2012
1Orbital Cellulitis
07/2012
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2011
1Fibroma (Fibromatosis)
11/2011
1Fibrosis (Cirrhosis)
11/2011
1Neuroma
11/2011
1Pain (Aches)
11/2011
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2011
1Gardner Syndrome
11/2011
1Dermoid Cyst (Dermoid)
08/2011

Drug/Important Bio-Agent (IBA)

10glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2015 - 10/2005
7DNA (Deoxyribonucleic Acid)IBA
10/2012 - 06/2002
5Erythema elevatum diutinumIBA
11/2015 - 02/2007
4Melanins (Melanin)IBA
10/2013 - 01/2002
4ParaffinIBA
02/2013 - 02/2004
4Formaldehyde (Formol)FDA Link
02/2013 - 02/2004
4Carbon MonoxideIBA
11/2011 - 02/2004
4CollagenIBA
11/2011 - 01/2002
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2008 - 09/2006
4Biological Markers (Surrogate Marker)IBA
01/2005 - 03/2003
3Proteins (Proteins, Gene)IBA
04/2010 - 02/2004
2FibrinIBA
04/2013 - 01/2010
2Periodic AcidIBA
04/2012 - 02/2009
2Keratins (Keratin)IBA
08/2011 - 08/2010
2Microphthalmia-Associated Transcription FactorIBA
02/2011 - 04/2010
2Interferon Type IIBA
12/2009 - 02/2006
2Plasminogen Activator Inhibitor 1IBA
01/2009 - 01/2007
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2009 - 01/2007
2Transforming Growth Factor beta (TGF-beta)IBA
01/2009 - 01/2007
2PerniosisIBA
04/2008 - 02/2007
2HemosiderinIBA
04/2008 - 10/2003
2infliximab (Remicade)FDA Link
01/2008 - 09/2006
2Immunoglobulins (Immunoglobulin)IBA
01/2008 - 09/2006
2rituximab (Mabthera)FDA Link
01/2008 - 09/2006
2Fluconazole (Zonal)FDA LinkGeneric
04/2007 - 08/2004
2AntibodiesIBA
02/2007 - 08/2002
2Antigen-Antibody Complex (Immune Complex)IBA
02/2007 - 12/2006
2Cyclin-Dependent Kinase Inhibitor p27IBA
11/2004 - 08/2004
1Erythema migransIBA
06/2015
1Doxycycline (Vibramycin)FDA LinkGeneric
06/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2013
1Phenobarbital (Luminal)FDA Link
04/2013
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
02/2013
1Familial cylindromatosisIBA
02/2013
1Amphotericin B (Amphotericin)FDA LinkGeneric
07/2012
1Antifungal AgentsIBA
07/2012
1Cyclin D1IBA
11/2011
1trichrome stainIBA
11/2011
1Attenuated familial adenomatous polyposisIBA
11/2011
1styrene-methylmethacrylate copolymerIBA
08/2011

Therapy/Procedure

2Biological Therapy
01/2008 - 09/2006
2Plasmapheresis
01/2008 - 09/2006
2Transplantation (Transplant Recipients)
08/2007 - 05/2002
2Transplants (Transplant)
08/2007 - 05/2002
1Radiotherapy
10/2013
1Drug Therapy (Chemotherapy)
10/2013
1Ileostomy
10/2012
1Ostomy
10/2012